Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of C...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288373/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8408658/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116800 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
